Skip to main content
Top
Published in: Diabetologia 10/2004

01-10-2004 | Short Communication

The complexity of non-enzymatic glycation product sets of human globins

Authors: A. Lapolla, M. Tubaro, R. Reitano, N. C. Aricò, E. Ragazzi, R. Seraglia, S. Vogliardi, P. Traldi, D. Fedele

Published in: Diabetologia | Issue 10/2004

Login to get access

Abstract

Aims/hypothesis

Recently an individual variability in the relationships between mean blood glucose levels and HbA1c has been observed among diabetic patients. The aim of this study was to provide an accurate description and evaluation of glycated and glyco-oxidated globins from diabetic subjects and their relationship with HbA1c and plasma glucose values.

Methods

We studied 20 Type 2 diabetic and 10 healthy subjects. Plasma samples were analysed by matrix-assisted laser desorption ionisation mass spectrometry.

Results

The presence of glycated and glyco-oxidated species of both α and β globin was demonstrated. Values for these showed a good linear relationship with HbA1c values and the mean daily plasma glucose values for the 6 weeks preceding the investigation. Trends differed according to whether patients had chronic complications or not, differences being seen in the slopes of the plots relating HbA1c to the abundance of glycated and glyco-oxidated species.

Conclusions/interpretation

The data obtained are consistent with the concept that individuals have a different individual proclivity for oxidation and/or that different oxidation kinetics are related to behavioural and environmental factors. Our data are thus relevant to the analysis of phenotype differences in diabetic patients.
Literature
1.
go back to reference Singh R, Barden A, Mori T, Beilin L (2001) Advanced glycation end-products: a review. Diabetologia 44:129–146CrossRefPubMed Singh R, Barden A, Mori T, Beilin L (2001) Advanced glycation end-products: a review. Diabetologia 44:129–146CrossRefPubMed
2.
go back to reference Schwartz JG (1995) The role of glycohemoglobin and other proteins in diabetes management. Diabetes Review 3:269–287 Schwartz JG (1995) The role of glycohemoglobin and other proteins in diabetes management. Diabetes Review 3:269–287
3.
go back to reference American Diabetes Association (2003) Tests of glycaemia in diabetes. Diabetes Care 26 [Suppl 1]:S106–S108 American Diabetes Association (2003) Tests of glycaemia in diabetes. Diabetes Care 26 [Suppl 1]:S106–S108
4.
go back to reference Hudson PR, Child FD, Jones H, Williams CP (1999) Differences in rates of glycation (glycation index) may significantly affect individual HbA1c results in type 1 diabetes. Ann Clin Biochem 36:451–459PubMed Hudson PR, Child FD, Jones H, Williams CP (1999) Differences in rates of glycation (glycation index) may significantly affect individual HbA1c results in type 1 diabetes. Ann Clin Biochem 36:451–459PubMed
5.
go back to reference Hempe JM, Gomez R, McCarter RJ, Chalew SA (2002) High and low haemoglobin glycation phenotypes in type 1 diabetes. A challenge for interpretation of glycemic control. J Diabetes Complications 16:313–320CrossRefPubMed Hempe JM, Gomez R, McCarter RJ, Chalew SA (2002) High and low haemoglobin glycation phenotypes in type 1 diabetes. A challenge for interpretation of glycemic control. J Diabetes Complications 16:313–320CrossRefPubMed
6.
go back to reference Lapolla A, Fedele D, Plebani M et al. (1999) Direct evaluation of glycated and glyco-oxidized globins by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 13:8–14CrossRefPubMed Lapolla A, Fedele D, Plebani M et al. (1999) Direct evaluation of glycated and glyco-oxidized globins by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 13:8–14CrossRefPubMed
7.
go back to reference Lapolla A, Fedele D, Plebani M et al. (1999) Evaluation of glycated globins by matrix-assisted laser desorption/ionization mass spectrometry. Clin Chem 45:288–290PubMed Lapolla A, Fedele D, Plebani M et al. (1999) Evaluation of glycated globins by matrix-assisted laser desorption/ionization mass spectrometry. Clin Chem 45:288–290PubMed
8.
go back to reference Pitt JJ, Gorman JJ (1996) Matrix assisted laser desorption/ionization time-of-flight mass spectrometry of sialylated glycopeptides and proteins using 2,6-dihydroxyacetophenone as a matrix. Rapid Commun Mass Spectrom 10:1786–1788CrossRef Pitt JJ, Gorman JJ (1996) Matrix assisted laser desorption/ionization time-of-flight mass spectrometry of sialylated glycopeptides and proteins using 2,6-dihydroxyacetophenone as a matrix. Rapid Commun Mass Spectrom 10:1786–1788CrossRef
9.
go back to reference Jeynes PK, Willis MC, Chon PP (1985) Evaluation of minicolumn chromatographic procedure for the measure of HbA1c. Clin Biochem 181:32–36 Jeynes PK, Willis MC, Chon PP (1985) Evaluation of minicolumn chromatographic procedure for the measure of HbA1c. Clin Biochem 181:32–36
10.
go back to reference Rohlfing CL, Wiedemeyer H, Little RR, England JD, Tennill A, Goldstein DE (2002) Defining the relationship between plasma glucose and HbA1c. Diabetes Care 25:275–278PubMed Rohlfing CL, Wiedemeyer H, Little RR, England JD, Tennill A, Goldstein DE (2002) Defining the relationship between plasma glucose and HbA1c. Diabetes Care 25:275–278PubMed
Metadata
Title
The complexity of non-enzymatic glycation product sets of human globins
Authors
A. Lapolla
M. Tubaro
R. Reitano
N. C. Aricò
E. Ragazzi
R. Seraglia
S. Vogliardi
P. Traldi
D. Fedele
Publication date
01-10-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1512-6

Other articles of this Issue 10/2004

Diabetologia 10/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.